National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

belinostat (beh-LIN-oh-STAT)

 A substance being studied in the treatment of cancer. Belinostat blocks enzymes needed for cell division and may kill cancer cells. It also prevents the growth of blood vessels needed for tumors to grow and may make tumor cells more sensitive to other anticancer drugs. It is a type of histone deacetylase (HDAC) inhibitor, a type of angiogenesis inhibitor, and a type of chemosensitizer. Also called PXD101.



Previous Definitions:BEACOPP regimen, Beckwith-Wiedemann syndrome, beclin 1, beclomethasone, behavior modification
Next Definitions:Bellini duct carcinoma, belotecan, belotecan hydrochloride, Bence Jones protein, bench-to-bedside

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov